Amsurg Corp. (NASDAQ:AMSG) Given Consensus Recommendation of “Buy” by Analysts
Shares of Amsurg Corp. (NASDAQ:AMSG) have earned a consensus rating of “Buy” from the thirteen ratings firms that are covering the firm. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $90.86.
A number of research firms have recently commented on AMSG. Citigroup Inc. began coverage on Amsurg Corp. in a report on Monday, September 26th. They issued a “buy” rating and a $79.00 price objective on the stock. Zacks Investment Research downgraded Amsurg Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Cantor Fitzgerald restated a “buy” rating and set a $95.00 price target on shares of Amsurg Corp. in a research note on Thursday, July 14th. Jefferies Group restated a “buy” rating on shares of Amsurg Corp. in a research note on Sunday, July 3rd. Finally, Mizuho raised their price target on Amsurg Corp. from $90.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, June 24th.
In other news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $63.65, for a total value of $477,375.00. Following the completion of the sale, the insider now directly owns 97,507 shares of the company’s stock, valued at approximately $6,206,320.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.30% of the stock is owned by insiders.
Several hedge funds have recently bought and sold shares of AMSG. Emerald Acquisition Ltd. purchased a new position in Amsurg Corp. during the second quarter valued at $106,000. Smith Asset Management Group LP increased its position in Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock valued at $133,000 after buying an additional 1,700 shares during the last quarter. Invictus RG increased its position in Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock valued at $142,000 after buying an additional 1,698 shares during the last quarter. Checchi Capital Advisers LLC purchased a new position in Amsurg Corp. during the second quarter valued at $157,000. Finally, Advisor Group Inc. purchased a new position in Amsurg Corp. during the second quarter valued at $202,000. 98.42% of the stock is owned by institutional investors and hedge funds.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded down 1.55% on Monday, reaching $66.01. The company’s stock had a trading volume of 310,680 shares. Amsurg Corp. has a 1-year low of $58.37 and a 1-year high of $87.29. The company has a market capitalization of $3.55 billion, a price-to-earnings ratio of 19.59 and a beta of 0.68. The stock has a 50-day moving average price of $65.46 and a 200-day moving average price of $73.45.
Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.02. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The business had revenue of $758.50 million for the quarter, compared to the consensus estimate of $769.88 million. During the same quarter in the prior year, the business posted $0.97 EPS. The business’s revenue for the quarter was up 21.5% on a year-over-year basis. On average, equities research analysts forecast that Amsurg Corp. will post $4.33 EPS for the current year.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Stock Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related stocks with our FREE daily email newsletter.